MARKETS WE SERVE IN SOUTH EAST ASIA
A Turnkey Solution To Commercialize Your Healthcare products in the Asia Pacific Region. We assist in Registrations and Business Development in the below mentioned Countries. We understand the legal requirements, cultural differences, geo-political situations in these countries and assist you in targeting the entire region via a Single Trusted Partner. The product portfolio we currently handle include Medical Devices, IVDs, cosmetics, and Neutraceuticals.
Global manufacturers are showing immense interest in South East Asian countries including Philippines, Indonesia, Malaysia, Thailand etc (business friendly approach of the new government). Companies either start the process with market research, registrations and/or distributor search. We at Morulaa have a direct hands-on approach for all these processes. We believe that every project has its own requirements. It is important to have a personal direct contact with these medical device distributors, regulators, KOLs, hospital and other healthcare professionals.
Below is the list of markets for which we provide Regulatory and Distribution Set-up Commercialize-ation services
Markets List the Commercialize-ation Services Provided:
China
India
Indonesia
Japan
Philippines
Vietnam
Thailand
Korea
Malaysia
Taiwan
Hong Kong
Singapore
To show that they are committed to encouraging foreign investments in the medical field, the governments are introducing a series of positive reforms including:
Foreign equity caps in various sectors were relaxed or removed.
Application of licenses made online
Validity of licenses increased to 3 years
Increase in foreign direct investments (FDI)
We have established collaborations with key companies across Asia Pacific and offer Regulatory and Commercialize-ation services across this region. Keep an eye on our blog to learn more about the regulatory and commercialize-ation service and requirements for various countries.
China: Population 1300 M
India: Population 1200 M
Indonesia: Population 246.9 M
Japan: Population 126 M
Philippines: Population 100 M
Vietnam: Population 88 M
Thailand: Population 70 M
Korea: Population 50 M
Malaysia: Population 30 M
Taiwan: Population 23 M
Hongkong: Population 7 M
Singapore: Population 5 M
Category
- News
- CDSCO
- CDSCO Amendments
- Classification
- Cosmetics
- Document Requirements
- Drugs
- Import
- India Market
- In-vitro Diagnostics
- Labelling
- PMS and Other Compliance
- Registration India
- Software as Medical Device
- SUGAM
- Timeline
- India Market
- Regulatory Consulting and Staffing
- EUDAMED
- Nutraceutical
- MDR
- MDR india
- Blog Morulaa
SPECIALTY HOSPITALS
Due to increasing lifestyle diseases, such as diabetes and coronary heart disease, Asia Pacific is a large marketplace for specialty hospitals.
MEDICAL TOURISM
Driven by rising affluence and increasing demand for quality healthcare, medical tourism is one of the top growth sectors in APAC in the short to medium term
HEALTHCARE IT
To remain competitive by increasing operational efficiency, clinical outcomes and financial profitability, private and public hospitals will invest extensively in installing, maintaining and upgrading IT capabilities.

UK MEDICAL DEVICE REGISTRATION: MHRA GUIDANCE SETS PATH FOR 2026 TRANSITION
United Kingdom, 25 February 2026 — The UK medical device registration landscape is the MHRA

UNDERSTANDING THE IMPACT OF UDI REQUIREMENTS FOR MEDICAL DEVICE MANUFACTURERS IN AUSTRALIA
Australia, 20 FEB 2026 – The Australian government has taken a significant step in enhancing

TEAM NB POSITION PAPER PUBLISHED: WHAT IVD MANUFACTURERS NEED TO KNOW ABOUT COMBINATORIAL USE
MDR & IVDR Proposed Revisions Published on 02/03/2026 The proposed updates to the MDR and

Mandatory TGA Adverse Event Reporting: A New Era of Vigilance for Australian Healthcare
SYDNEY, 18, FEB 2026 – The landscape of medical device safety in Australia has officially